Trials / Sponsors / Shenzhen Genocury Biotech Co., Ltd.
Shenzhen Genocury Biotech Co., Ltd.
Industry · 4 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Cluster of Differentiation 19 (CD19)/B Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor T-Cell (CAR-T) Autoimmune Diseases | N/A | 2026-03-22 |
| Recruiting | JY232(JY232) Injection in Relapsed/Refractory Multiple Myeloma Multiple Myeloma | EARLY_Phase 1 | 2026-01-20 |
| Recruiting | JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia B Acute Lymphoblastic Leukemia, B-Non Hodgkin Lymphoma | N/A | 2025-03-01 |
| Recruiting | JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia B-NHL, B-ALL | N/A | 2023-09-07 |